Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Anogenital warts
ADR ID BADD_A05663
ADR Hierarchy
07      Gastrointestinal disorders
07.19      Gastrointestinal infections
07.19.04      Anal, rectal, perianal and perirectal infections
07.19.04.002      Anogenital warts
11      Infections and infestations
11.05      Viral infectious disorders
11.05.07      Papilloma viral infections
11.05.07.002      Anogenital warts
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.26      Cutaneous neoplasms benign
16.26.01      Skin neoplasms benign
16.26.01.003      Anogenital warts
21      Reproductive system and breast disorders
21.10      Reproductive tract disorders NEC
21.10.03      Reproductive tract infections and inflammations NEC
21.10.03.004      Anogenital warts
23      Skin and subcutaneous tissue disorders
23.10      Cutaneous neoplasms benign
23.10.01      Skin neoplasms benign
23.10.01.003      Anogenital warts
Description Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses. [MeSH]
MedDRA Code 10059313
MeSH ID D003218
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anal warts | Condyloma acuminatum | Condyloma virus genital infections | Condylomata acuminata | Condylomata acuminatum | Genital warts | Perianal warts | Venereal warts | Genital wart | Condyloma | Condyloma anal | Anogenital warts | Condyloma accuminata recurrent | Perineal warts | Condylomata Acuminata | Venereal Warts | Venereal Wart | Wart, Venereal | Warts, Venereal | Genital Warts | Genital Wart | Wart, Genital | Warts, Genital
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00734Duloxetine0.000132%
BADD_D00766Emtricitabine--
BADD_D00898Finasteride0.001283%
BADD_D01142Imiquimod0.002317%
BADD_D01253Lenalidomide--
BADD_D01265Levetiracetam0.000381%
BADD_D01281Levonorgestrel0.004169%
BADD_D01352Maraviroc--
BADD_D02105Tacrolimus0.004968%
BADD_D02236Tofacitinib0.001737%
BADD_D02464Fingolimod0.011580%
The 1th Page    1    Total 1 Pages